Hyperprogression in PD-L1 ≥ 50% NSCLC: a Biomarker Guided Phase 2 Trial

Clinical trial NCT07274384 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07274384
Sponsor: Università Vita-Salute San Raffaele
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

NSCLC (Non-small Cell Lung Cancer)Hyperprogression

Start date: 2026-01-01
Primary completion: 2029-12-31
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.